Studies of cardiomyocyte-specific knockout (KO) or transgenic IGF-1R mice showed that IGF-1R activates phosphoinositide 3-kinase (PI3K)Akt signaling pathways through its intrinsic tyrosine kinase activity and regulates cardiomyocyte survival, hypertrophy, and aging [5,6,7]
Its a very unique situation because the extent of the anecdotal data has really outpaced any clinical data that we have available right now, Hendershot tells TODAY.com
[8],[53-55] Therefore, the inclusion of GLP-1RA or SGLT2i at the time of diagnosis of T2D in patients with ASCVD or multiple risk factors is a reasonable option and aligns with the views of Diabetes Canada
Let's understand that now What are GLP-1 Agonists
In the STEP 1 trial of the FDA-approved branded product, adults lost about 15% of body weight on average over 68 weeks alongside lifestyle changes, and roughly one in three lost 20% or more